本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

158.14
-0.9900-0.62%
盘后158.140.00000.00%19:14 EDT
成交量:43.28万
成交额:6,866.43万
市值:95.08亿
市盈率:-23.39
高:161.87
开:161.50
低:155.96
收:159.13
数据加载中...
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities